Novo Nordisk faces FDA scrutiny over unreported Ozempic side effects, including deaths and a suicide, amid struggles to compete with Eli Lilly in the US obesity drug market. Despite risks like nausea and pancreatitis, Ozempic helps control blood sugar, slow digestion, and reduce appetite.
​Novo Nordisk faces FDA scrutiny over unreported Ozempic side effects, including deaths and a suicide, amid struggles to compete with Eli Lilly in the US obesity drug market. Despite risks like nausea and pancreatitis, Ozempic helps control blood sugar, slow digestion, and reduce appetite. by Soban News (international And National News)
